BERLIN—Bayer AG unveiled on Wednesday billions in new costs cuts to offset falling demand in agricultural products—the market on which it had made a huge bet with its acquisition of Monsanto.
The German chemicals and pharmaceuticals company said the coronavirus pandemic would hit its crop-science business harder than anticipated as prices for various crops fell, consumption of biofuel decreased and competition in the soy market intensified.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterBecome a founding member
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe